Access the full text.
Sign up today, get DeepDyve free for 14 days.
Zutter (1988)
520Blood, 72
E. Campo, E. Jaffe, J. Cook, L. Quintanilla‐Martinez, S. Swerdlow, K. Anderson, P. Brousset, L. Cerroni, L. Leval, S. Dirnhofer, A. Dogan, A. Feldman, F. Fend, J. Friedberg, P. Gaulard, P. Ghia, S. Horwitz, R. King, G. Salles, J. San-Miguel, J. Seymour, S. Treon, J. Vose, E. Zucca, R. Advani, S. Ansell, W. Au, C. Barrionuevo, P. Bergsagel, W. Chan, J. Cohen, A. Davies, B. Falini, I. Ghobrial, J. Goodlad, J. Gribben, E. Hsi, B. Kahl, W. Kim, Shaji Kumar, A. LaCasce, C. Laurent, G. Lenz, J. Leonard, M. Link, A. López-Guillermo, M. Mateos, E. Macintyre, A. Melnick, F. Morschhauser, S. Nakamura, M. Narbaitz, A. Pavlovsky, S. Pileri, M. Piris, B. Pro, S. Rajkumar, S. Rosen, B. Sander, L. Sehn, M. Shipp, Sonali Smith, L. Staudt, C. Thieblemont, T. Tousseyn, W. Wilson, T. Yoshino, P. Zinzani, M. Dreyling, D. Scott, J. Winter, A. Zelenetz (2022)
The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee.Blood
F. Kinsella, M. Kashipaz, J. Scarisbrick, R. Malladi (2017)
Donor-derived mycosis fungoides following reduced intensity haematopoietic stem cell transplantation from a matched unrelated donorBMJ Case Reports, 2017
M. Gambacorta, E. Bonacina, B. Falini, E. Sabattini, S. Pileri (1991)
Malignant lymphoma in the recipient of a heart transplant from a donor with malignant lymphoma. Lymphoma transplantation or de novo disease?Transplantation, 51 4
B. Hertenstein, L. Hambach, A. Bacigalupo, N. Schmitz, S. McCann, S. Slavin, A. Gratwohl, A. Ferrant, A. Elmaagacli, Rainer Schwertfeger, A. Locasciulli, A. Zander, M. Bornhäuser, D. Niederwieser, T. Ruutu (2005)
Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT).Haematologica, 90 7
M. Zutter, P. Martin, G. Sale, H. Shulman, L. Fisher, Thomas Ed, D. Durnam (1988)
Epstein-Barr virus lymphoproliferation after bone marrow transplantation.Blood, 72 2
Afiat (2018)
72Leuk Res Rep., 9
Angel Santos-Briz, A. Romo, P. Antunez, C. Román, M. Alcoceba, Juan García, Lourdes Vázquez, Marcos González, P. Unamuno (2009)
Primary cutaneous T‐cell lymphoproliferative disorder of donor origin after allogeneic haematopoietic stem‐cell transplantationClinical and Experimental Dermatology, 34
Sammie Roberts, Brandon McNally, Julie Rosser, Nicholas Willard, L. Golitz, J. Wisell (2019)
Diverse clinical and histopathologic features of cutaneous post‐transplant lymphoproliferative disorders: A presentation of two casesAustralasian Journal of Dermatology, 60
Caoimhe Fahy, Anne Fortune, F. Quinn, Máirín McMenamin, Paul Browne, S. Langabeer, Sarah McCarron, P. Hayden, P. Marren, M. Chonghaile, Alan Irvine, Elisabeth Vandenberghe, L. Barnes (2014)
Development of mycosis fungoides after bone marrow transplantation for chronic myeloid leukaemia: transmission from an allogeneic donorBritish Journal of Dermatology, 170
K. Berg, Nooshin Brinster, Karen Huhn, Michael Goggins, Richard Jones, Adel Makary, Kathleen Murphy, Constance Griffin, Lynne Rosenblum-Vos, Michael Borowitz, Hossein Nousari, James Eshleman (2001)
Transmission of a T-cell lymphoma by allogeneic bone marrow transplantation.The New England journal of medicine, 345 20
R. Mehta, Carlos Cabala, C. Dinardo, N. Daver, B. Dabaja, K. Rezvani, R. Champlin, E. Shpall, M. Duvic (2021)
Post‐transplantation donor‐derived Sezary syndrome in a patient with A91V PRF1 variant hemophagocytic lymphohistiocytosisAmerican Journal of Hematology, 96
Thanh-Phuong Afiat, Xiaohui Zhang, Hailing Zhang, E. Ayala, Ling Zhang, L. Sokol (2018)
Sezary syndrome manifesting as posttransplant lymphoproliferative disorderLeukemia Research Reports, 9
J. Loh, D. Cassarino, W. Grody, M. Chiu, L. Pinter-Brown (2014)
A case of mycosis fungoides transmitted from donor to recipient, and review of literature of T-cell malignancies after transplantation.Clinical lymphoma, myeloma & leukemia, 14 4
Anna Kawashiri, Shunsuke Nakagawa, Chisato Ishiguro, K. Mochizuki, Y. Maeda, T. Kurokawa (2022)
Donor-derived diffuse large B-cell lymphoma after haploidentical stem cell transplantation for acute myeloid leukemiaJournal of Clinical and Experimental Hematopathology : JCEH, 62
D. Dierickx, T. Habermann (2018)
Post‐Transplantation Lymphoproliferative Disorders in AdultsThe New England Journal of Medicine, 378
Hertenstein (2005)
969Haematologica, 90
J. Goodlad, L. Cerroni, S. Swerdlow (2022)
Recent advances in cutaneous lymphoma—implications for current and future classificationsVirchows Archiv, 482
O. Servitje, C. Muniesa, Y. Benavente, V. Monsálvez, M. García-Muret, F. Gallardo, E. Domingo-Domènech, A. Lucas, F. Climent, J. Rodríguez-Peralto, P. Ortiz-Romero, J. Sandoval, R. Pujol, M. Estrach (2013)
Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.Journal of the American Academy of Dermatology, 69 3
AbstractPrimary cutaneous posttransplant lymphoproliferative disorders (PTLDs) after allogeneic hematopoietic stem cell transplant (allo-HSCT) are exceedingly rare, with only 6 published cases, all of them consisting in T-cell neoplasms. In this report, we present for the first time a donor-derived B-cell PTLD consisting in a primary, cutaneous, B-cell, marginal zone, lymphoproliferative disorder (PCMZLPD). The patient, a 37-year-old woman with a history of Hodgkin lymphoma received an allo-HSCT from her healthy, matched, related father, achieving complete host chimerism in the bone marrow and peripheral blood. However, 8 years after the allo-HSCT, she presented asymptomatic skin lesions consisting in oval, well-defined, slightly raised erythematous plaques, located on the arms, trunk, and legs. Skin biopsies of 2 lesions demonstrated a class-switched IgG+, EBV-, PCMZLPD, showing kappa light chain restriction and monoclonal rearrangement of the IgH gene. Microsatellite genotyping and 2-color fluorescence in situ hybridization (X and Y chromosomes) confirmed that the origin of the neoplastic cells was the donor graft. The lesions showed an indolent behavior, good response to topical corticosteroids, and no need for systemic treatment. Our case broadens the spectrum of PTLD, a diverse group of lymphoid and/or plasmacytic proliferations with variable clinical presentations and histopathological features.
The American Journal of Dermatopathology – Wolters Kluwer Health
Published: Jun 1, 2023
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.